Issues and perspectives on the biocompatibility and immunotoxicity evaluation of implanted controlled release systems

Journal of Controlled Release

Volumn 57, Issue 2, 1999, Pages 107-113

  Anderson, James M ^a   Langone, John J ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Biocompatibility; Controlled release; Immunotoxicity

Indexed keywords

BIOMATERIAL;

BIOCOMPATIBILITY; DRUG CLASSIFICATION; DRUG DELIVERY SYSTEM; FOOD AND DRUG ADMINISTRATION; IMMUNOTOXICITY; INTERNATIONAL COOPERATION; MATERIALS TESTING; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; STANDARD; SUSTAINED DRUG RELEASE;

EID: 0032946537     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(98)00178-3     Document Type: Article

References (21)

1. AAMI Standards and Recommended Practices, Vol. 4, Biological Evaluation of Medical Devices, Association for the Advancement of Medical Instrumentation, 1996.
2. Office of Device Evaluation, Center for Devices and Radiological Health, Food and Drug Administration, Rockville, MD, 1995.
3. Chapekar M.S. Regulatory concerns in the development of biologic-biomaterial combinations. J. Biomed. Mater. Res. Appl. Biomat. 33:1996;199-203.
4. Yamaguchi K., Anderson J.M. Biocompatibility studies of naltrexone sustained release formulations. J. Control. Release. 19:1992;299-314.
5. ® 65/35 D,L- lactide/glycolide copolymer microspheres. J. Control. Release. 24:1993;81-93.
6. Anderson J.M. In vivo biocompatibility of implantable delivery systems and biomaterials. Eur. J. Pharm. Biopharm. 40(1):1994;1-8.
7. Anderson J.M., Shive M.S. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv. Drug Deliv. Rev. 28:1997;5-24.
8. J.J. Langone, Immunotoxicity Testing Guidance, Draft Document. Office of Science and Technology, Center for Devices and Radiological Health, Food and Drug Administration, 1998.
9. J.M. Cruse, R.E. Lewis (Eds.), Illustrated Dictionary of Immunology, CRC Press, Boca Raton, FL, 1995.
10. E. Benjamini, G. Sushine, S. Leskowitz, Immunology: A Short Course, third ed., Wiley-Liss, New York, 1996.
11. C.A. Janeway Jr., P. Travers, Immunobiology: The Immune System in Health and Disease, third ed., Current Biology - Garland, New York, 1997.
12. N.R. Rose, E.C. de Mecario, J.D. Folds, H.C. Lane, R.M. Nakamura (Eds.), Manual of Clinical Laboratory Immunology, ASM Press, Washington, DC, 1997.
13. R.J. Smialowicz, M. P. Holsapple (Eds.), Experimental Immunotoxicology, CRC Press, Boca Raton, FL, 1996.
14. G.R. Burleson, J.H. Dean, A.E. Munson (Eds.), Methods in Immunotoxicology, Wiley-Liss, New York, 1995.
15. J.E. Coligan, A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, R. Strober (Eds.), Current Protocols in Immunology, Greene Publishing Associates and Wiley Interscience, New York, 1992.
16. N.R. Rose, in: M.S. Lefell, A.D. Donnenberg, N.R. Rose (Eds.), Immunologic Diagnosis of Autoimmune Disease, CRC Press, Boca Raton, FL, 1997, pp. 111-123.
17. I.R. Cohen, A. Miller (Eds.), Autoimmune Disease Models: A Guidebook, Academic Press, New York, 1994.
18. R.A. Greenwald, H.S. Diamond (Eds.), Handbook of Animal Models for the Rheumatic Diseases, Vol. I, CRC Press, Boca Raton, FL, 1988.
19. Cleland J.L., Duenas E., Daugherty A., Marian M., Yang J., Wilson M., Celniker A.C., Shahzamani A., Quarmby V., Chu H., Mukku V., Mac A., Roussakis M., Gillette N., Boyd B., Yeung D., Brooks D., Maa Y-F., Hsu Ch., Jones A.J.S. Recombinant human growth hormone poly(lactic-co-glycolic acid) (PLGA) microspheres provide a long lasting effect. J. Control. Release. 49:1997;193-205.
20. Stewart T.A. Models of human endocrine disorders in transgenic rodents. Trends Endocrinol. Metab. 4:1993;136-141.
21. Stewart T.A., Hollinghead P.G., Pitts S.L., Chang R., Martin L.E., Oakley H. Transgenic mice as a model to test the immunogenicity of proteins altered by site-specific mutagenesis. Mol. Biol. Med. 6:1989;275-281.